Jenny Karlsson

Jenny Karlsson

Company: Bayer

Job title: Head of TRP Biochemistry


14 years industrial experience of research and development of antibody-based therapies, protein engineering and conjugation technologies, with a PhD in Biochemistry from Göteborgs University. Currently at the Targeted Radiopharmaceutical department, Bayer AS, focusing on targeted alpha therapy (TAT) with three targeted thorium conjugates (TTCs) in clinical Phase I.

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.